Co-Diagnostics announces annual shareholder meeting

• Co-Diagnostics schedules its annual shareholder meeting in Salt Lake City on Sept. 3, 2026.
• Vote set for five director seats, covering the full board.
• Shareholders to decide on adding 2,000,000 shares to the 2025 Equity Incentive Plan share reserve.
• Ballot includes a nonbinding say-on-pay vote, auditor ratification for Tanner LLC, a lower quorum threshold, adjournment authority.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034021), on July 21, 2026, and is solely responsible for the information contained therein.